Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression
Public ClinicalTrials.gov record NCT03482882. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults With Parkinson's Disease and Depression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the efficacy of pimavanserin for the treatment of depression in adults with Parkinson's disease.
Study identification
- NCT ID
- NCT03482882
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 47 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 9, 2018 (Actual)
- Primary completion
- Jul 9, 2019 (Actual)
- Completion
- Jul 24, 2019 (Actual)
- Last update posted
- Aug 31, 2020
2018 – 2019
United States locations
- U.S. sites
- 21
- U.S. states
- 10
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ATP Clinical Research, Inc. | Costa Mesa | California | 92626 | — |
| The Parkinson's and Movement Disorder Institute | Fountain Valley | California | 92708 | — |
| SC3 Research-Reseda | Pasadena | California | 91105 | — |
| The Neurology Group | Pomona | California | 91767 | — |
| SC3 Research-Reseda | Reseda | California | 91335 | — |
| CNS Network | Torrance | California | 90502 | — |
| Associated Neurologists, P.C. | Danbury | Connecticut | 06810 | — |
| Parkinson's Disease and Movement Disorder Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| University of Florida | Gainesville | Florida | 32607 | — |
| Parkinson's Disease Treatment Center of SW Florida | Port Charlotte | Florida | 33980 | — |
| Infinity Clinical Research, LLC | Sunrise | Florida | 33351 | — |
| Tallahassee Neurological Clinic, P.A. | Tallahassee | Florida | 32308 | — |
| SRI Biosciences, Clinical Trials and Strategic Development Services | Plymouth | Michigan | 48170 | — |
| Washington University School of medicine | St Louis | Missouri | 63110 | — |
| Bio Behavioral Health | Toms River | New Jersey | 08755 | — |
| Albany Medical College | Albany | New York | 12208 | — |
| David L. Kreitzman, MD, PC | Commack | New York | 11725 | — |
| Asheville Neurology Specialists, PA | Asheville | North Carolina | 28806 | — |
| Neurology/Neurophysiology | Johnstown | Pennsylvania | 15904 | — |
| Booth Gardner Parkinson's Care Center | Kirkland | Washington | 98034 | — |
| Inland Northwest Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03482882, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2020 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03482882 live on ClinicalTrials.gov.